ADO-5030

Adovate · Phase 1 active Small molecule

At a glance

Generic name	ADO-5030
Sponsor	Adovate
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

ADO-5030 in Bronchoconstriction Challenge, Phase 1b (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ADO-5030 CI brief — competitive landscape report
ADO-5030 updates RSS · CI watch RSS
Adovate portfolio CI